Cite
HARVARD Citation
Glenthøj, A. et al. (2022). Mitapivat in adult patients with pyruvate kinase deficiency receiving regular transfusions (ACTIVATE-T): a multicentre, open-label, single-arm, phase 3 trial. Lancet. 9 (10), pp. e724-e732. [Online].